Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

Disparities in breast cancer characteristics and outcomes by race/ethnicity

(2010) Siew Loon Ooi et al.   BREAST CANCER RESEARCH AND TREATMENT

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

(2010) Dawn L. Hershman et al.   BREAST CANCER RESEARCH AND TREATMENT

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care

(2010) Rachel A. Freedman et al.   CANCER

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

(2010) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

(2009) Sara Alkner et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer

(2009) Gretchen Kimmick et al.   JOURNAL OF CLINICAL ONCOLOGY

Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view

(2009) Isabelle Pellegrini et al.   PSYCHO-ONCOLOGY

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY